Pharmaceutical News

RSS

BioGaia inks distribution agreement for ProTectis baby drops and tablets in China

BioGaia has signed an agreement with Beijing Keyuan Xinhai Pharmaceutical Co Ltd for the exclusive rights to sell BioGaia's ProTectis baby drops and ProTectis and Gastrus tablets through the retail pharmacy channel in China from 2013.

13 May 2013

CompCare, UticaCSD sign Pharmacy Savings Management Agreement

Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management services provider for employers, Taft-Hartley health and welfare Funds, and managed care companies throughout the U.S., today announced the signing of a Pharmacy Savings Management Agreement with Utica City School District.

13 May 2013

Study confirms that success of sunless tanning products depends on young women

Sunless tanning - whether with lotions, bronzers or tanning pills - has been promoted as an effective substitute to dodge the health risks of ultraviolet rays, but if the products don't provide the perfect tan, young women likely will not use them, according to a Baylor University researcher.

13 May 2013

Senate bill on FDA oversight of compounding pharmacies gets broad backing as hearings move closer

A bill to give the FDA greater authority over compounding pharmacies like the one behind a deadly meningitis outbreak gets broad -- including bipartisan -- backing, and a key committee chairman readies a hearing on the legislation.

13 May 2013

Scientists make novel discoveries concerning current vaccine against whooping cough

Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine.

13 May 2013

Researchers successfully test new anti-cocaine vaccine in primates

Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials.

13 May 2013

Researchers identify clue to explain the reversible memory loss caused by statins

The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering drugs.

13 May 2013

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

13 May 2013

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by researchers at the Knight Cancer Institute at Oregon Health & Science University.

13 May 2013

Study: Metformin may not improve survival rates after breast cancer

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

10 May 2013

Cinnamon-flavored foods contain high levels of natural substance that may cause liver damage

Many kinds of cinnamon, cinnamon-flavored foods, beverages and food supplements in the United States use a form of the spice that contains high levels of a natural substance that may cause liver damage in some sensitive people, scientists are reporting. Their study, published in ACS' Journal of Agricultural and Food Chemistry, found similar results as those published in the European Union.

10 May 2013

DURECT: Pfizer provides update on investigational drug Remoxy

DURECT Corporation today announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing.

10 May 2013

Expiring patents drive drug spending's first time fall

Patient spending on prescription drugs fell in 2012 -- for the first time ever, a new study reports -- due in part to expiring patents on brand-name drugs.

10 May 2013

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

ScinoPharm Taiwan Ltd. and Coland Holdings Ltd. announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.

9 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

Products from The Compounding Shop lack sterility assurance, FDA warns

The U.S. Food and Drug Administration is alerting health care providers, hospital supply managers, and pharmacists that the FDA's preliminary findings of practices at The Compounding Shop of St. Petersburg, Fla., raise concerns about a lack of sterility assurance for sterile drugs produced at and distributed from this site.

9 May 2013

Antitumor medication from natural origins on the rise

Natural phenolic compounds play an important role in cancer prevention and treatment. Researchers who examine the medicinal herbs and dietary plants that can aid in cancer treatment and prevention have found that antitumor medication from natural origins is on the rise.

9 May 2013

Pharmaceutical News

BioGaia inks distribution agreement for ProTectis baby drops and tablets in China

CompCare, UticaCSD sign Pharmacy Savings Management Agreement

Study confirms that success of sunless tanning products depends on young women

Senate bill on FDA oversight of compounding pharmacies gets broad backing as hearings move closer

Scientists make novel discoveries concerning current vaccine against whooping cough

Researchers successfully test new anti-cocaine vaccine in primates

Researchers identify clue to explain the reversible memory loss caused by statins

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Study: Metformin may not improve survival rates after breast cancer

Cinnamon-flavored foods contain high levels of natural substance that may cause liver damage

DURECT: Pfizer provides update on investigational drug Remoxy

Expiring patents drive drug spending's first time fall

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Products from The Compounding Shop lack sterility assurance, FDA warns

Antitumor medication from natural origins on the rise

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News